These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 3698863

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pulmonary complications in patients with inflammatory bowel disease.
    Kuzela L, Vavrecka A, Prikazska M, Drugda B, Hronec J, Senkova A, Drugdova M, Oltman M, Novotna T, Brezina M, Kratky A, Kristufek P.
    Hepatogastroenterology; 1999; 46(27):1714-9. PubMed ID: 10430329
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
    Winterkamp S, Weidenhiller M, Otte P, Stolper J, Schwab D, Hahn EG, Raithel M.
    Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
    [Abstract] [Full Text] [Related]

  • 6. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V, Piepoli A, Perri F, Lombardi G, Latiano A, Napolitano G, Corritore G, Vandewalle P, Poulain D, Colombel JF, Andriulli A.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1143-52. PubMed ID: 15569117
    [Abstract] [Full Text] [Related]

  • 7. The comorbid occurrence of other diagnoses in patients with ulcerative colitis and Crohn's disease.
    Cucino C, Sonnenberg A.
    Am J Gastroenterol; 2001 Jul 15; 96(7):2107-12. PubMed ID: 11467640
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
    Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F.
    J Bone Miner Res; 1995 Feb 15; 10(2):250-6. PubMed ID: 7754804
    [Abstract] [Full Text] [Related]

  • 12. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
    Pimentel M, Chang M, Chow EJ, Tabibzadeh S, Kirit-Kiriak V, Targan SR, Lin HC.
    Am J Gastroenterol; 2000 Dec 15; 95(12):3458-62. PubMed ID: 11151877
    [Abstract] [Full Text] [Related]

  • 13. Cancer in patients with ulcerative colitis, Crohn's disease and coeliac disease: record linkage study.
    Goldacre MJ, Wotton CJ, Yeates D, Seagroatt V, Jewell D.
    Eur J Gastroenterol Hepatol; 2008 Apr 15; 20(4):297-304. PubMed ID: 18334873
    [Abstract] [Full Text] [Related]

  • 14. [Familial prevalence in chronic intestinal inflammatory disease. Differences among groups of patients with and without a familial history].
    Nos P, Argüello L, Hoyos M, Ramírez JJ, Hinojosa J, Molés JR, García A, Berenguer M, Berenguer J.
    Rev Esp Enferm Dig; 1996 Jul 15; 88(7):470-4. PubMed ID: 8924324
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Crohn's disease and indeterminate colitis and the ileal pouch-anal anastomosis: outcomes and patterns of failure.
    Brown CJ, Maclean AR, Cohen Z, Macrae HM, O'Connor BI, McLeod RS.
    Dis Colon Rectum; 2005 Aug 15; 48(8):1542-9. PubMed ID: 15937625
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T, May B, Pfisterer O, Müller KM, Brasch F.
    Hepatogastroenterology; 2002 Aug 15; 49(43):116-23. PubMed ID: 11941933
    [Abstract] [Full Text] [Related]

  • 18. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
    Bernstein CN, Papineau N, Zajaczkowski J, Rawsthorne P, Okrusko G, Blanchard JF.
    Am J Gastroenterol; 2000 Mar 15; 95(3):677-83. PubMed ID: 10710056
    [Abstract] [Full Text] [Related]

  • 19. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C, Wiebecke B, Loeschke K.
    Am J Gastroenterol; 1999 Jun 15; 94(6):1551-5. PubMed ID: 10364024
    [Abstract] [Full Text] [Related]

  • 20. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission.
    Herrlinger KR, Noftz MK, Dalhoff K, Ludwig D, Stange EF, Fellermann K.
    Am J Gastroenterol; 2002 Feb 15; 97(2):377-81. PubMed ID: 11866276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.